ProfileGDS5678 / 1451258_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 31% 30% 30% 31% 30% 33% 28% 30% 31% 30% 30% 30% 29% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7281831
GSM967853U87-EV human glioblastoma xenograft - Control 22.6830330
GSM967854U87-EV human glioblastoma xenograft - Control 32.6887330
GSM967855U87-EV human glioblastoma xenograft - Control 42.6556631
GSM967856U87-EV human glioblastoma xenograft - Control 52.625630
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.833433
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.683228
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6644830
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6847131
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6761730
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6732230
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6611530
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6703129
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6774730